Stay updated on Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page.

Latest updates to the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedA new Locations section appears listing sites in Nevada, New Jersey, and South Carolina. The older state-specific location subsections were removed, and the footer’s HHS Vulnerability Disclosure link was deleted.SummaryDifference0.3%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing the previous Revision: v3.2.0; to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check43 days agoChange DetectedThe banner about a lapse in government funding has been removed from the page. The study details and links remain intact.SummaryDifference0.3%

- Check57 days agoChange DetectedThe two screenshots show no changes to core study information; only layout/UI presentation differs. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check86 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

- Check93 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page.